Aarti Drugs Limited (NSE: AARTIDRUGS), ISIN INE767A01016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
AARTIDRUGS last traded at ₹413.00 (+1.41%), with a 52-week range of ₹318.60 to ₹549.00 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 54.43%, FIIs 1.52%, DIIs 10.29%, mutual funds 10.08%.
EquiSense Score (ECS): 64/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.